会议预告2026年4月9-10日即将在苏州举办新一届年度盛会:2026小分子药物创新开发大会,围绕7大主题:小分子研发前沿与BD出海、创新机制疗法与靶点发现、CMC与质量控制、不可成药靶点PROTAC、分子胶、合成致死靶点、AI与高通量筛选分子设计、CNS及代谢/抗病毒疾病领域等专题12月9日,华领医药(“公司”,香港联交所股份代号:2552.HK)宣布,公司自主研发的第二代葡萄糖激酶激活剂(...
Source Link会议预告2026年4月9-10日即将在苏州举办新一届年度盛会:2026小分子药物创新开发大会,围绕7大主题:小分子研发前沿与BD出海、创新机制疗法与靶点发现、CMC与质量控制、不可成药靶点PROTAC、分子胶、合成致死靶点、AI与高通量筛选分子设计、CNS及代谢/抗病毒疾病领域等专题12月9日,华领医药(“公司”,香港联交所股份代号:2552.HK)宣布,公司自主研发的第二代葡萄糖激酶激活剂(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.